Dysregulations of Functional RNA Modifications in Cancer, Cancer Stemness and Cancer Therapeutics.
Reads0
Chats0
TLDR
It is concluded that, while advanced technologies have uncovered the contributions of many of RNA modifications in cancer, the underlying mechanisms are still poorly understood and further studies are needed to elucidate the mechanism of how RNA modifications promote cell malignant transformation and generation of cancer stem cells, which will lead to the development of new strategies for cancer prevention and treatment.Abstract:
More than a hundred chemical modifications in coding and non-coding RNAs have been identified so far. Many of the RNA modifications are dynamic and reversible, playing critical roles in gene regulation at the posttranscriptional level. The abundance and functions of RNA modifications are controlled mainly by the modification regulatory proteins: writers, erasers and readers. Modified RNA bases and their regulators form intricate networks which are associated with a vast array of diverse biological functions. RNA modifications are not only essential for maintaining the stability and structural integrity of the RNA molecules themselves, they are also associated with the functional outcomes and phenotypic attributes of cells. In addition to their normal biological roles, many of the RNA modifications also play important roles in various diseases particularly in cancer as evidenced that the modified RNA transcripts and their regulatory proteins are aberrantly expressed in many cancer types. This review will first summarize the most commonly reported RNA modifications and their regulations, followed by discussing recent studies on the roles of RNA modifications in cancer, cancer stemness as wells as functional RNA modification machinery as potential cancer therapeutic targets. It is concluded that, while advanced technologies have uncovered the contributions of many of RNA modifications in cancer, the underlying mechanisms are still poorly understood. Moreover, whether and how environmental pollutants, important cancer etiological factors, trigger abnormal RNA modifications and their roles in environmental carcinogenesis remain largely unknown. Further studies are needed to elucidate the mechanism of how RNA modifications promote cell malignant transformation and generation of cancer stem cells, which will lead to the development of new strategies for cancer prevention and treatment.read more
Citations
More filters
Journal ArticleDOI
The m 6 A RNA methylation regulates oncogenic signaling pathways driving cell malignant transformation and carcinogenesis
TL;DR: The m6A RNA methylation is the most prevalent internal modification in mammalian mRNAs which plays critical biological roles by regulating vital cellular processes Dysregulations due to aberrant expression of its regulatory proteins are frequently observed in many pathological conditions, particularly in cancer Normal cells undergo malignant transformation via activation or modulation of different oncogenic signaling pathways through complex mechanisms as discussed by the authors.
Journal ArticleDOI
Role of main RNA modifications in cancer: N6-methyladenosine, 5-methylcytosine, and pseudouridine
TL;DR: In this article , the role of RNA modifications in cancer progression has become increasingly prominent and is a hot spot in scientific research, which refers to heritable modifications in the genetic material without any changes in the nucleic acid sequence and results in heritable phenotypic changes.
Journal ArticleDOI
Context-Dependent Roles of RNA Modifications in Stress Responses and Diseases.
TL;DR: The role of RNA modifications in response to these cellular stressors is context-and cell-type-dependent as mentioned in this paper, and they have been implicated in the pathogenesis of different diseases, including cancer, neurologic and developmental disorders and diseases, and metabolic diseases.
Journal ArticleDOI
Potential regulatory role of epigenetic RNA methylation in cardiovascular diseases.
TL;DR: In this paper, the role of RNA methylation in the pathophysiology of CVDs and the potential of using epigenetics to treat such disorders was summarized, and several approaches have been proposed for the prevention and treatment of cardiovascular diseases.
Journal ArticleDOI
Comprehensive profiling and evaluation of the alteration of RNA modifications in thyroid carcinoma by liquid chromatography-tandem mass spectrometry
TL;DR: Wang et al. as discussed by the authors carried out the comprehensive profiling and evaluation of the alteration of RNA modifications in thyroid carcinoma by liquid chromatography-tandem mass spectrometry (LC-ESI-MS/MS) analysis.
References
More filters
Journal ArticleDOI
Oxidative demethylation of 3-methylthymine and 3-methyluracil in single-stranded DNA and RNA by mouse and human FTO
TL;DR: It is demonstrated that methylated RNAs are the preferred substrates for FTO, and that these two proteins can catalyze the demethylation of 3‐meU in ssRNA with a slightly higher efficiency over that of 3-meT in ssDNA.
Journal ArticleDOI
Grand Challenge Commentary: RNA epigenetics?
TL;DR: Post-transcriptional RNA modifications can be dynamic and might have functions beyond fine-tuning the structure and function of RNA that allow researchers to identify new layers of gene regulation at the RNA level.
Journal ArticleDOI
HBXIP-elevated methyltransferase METTL3 promotes the progression of breast cancer via inhibiting tumor suppressor let-7g.
Xiaoli Cai,Xiao Wang,Can Cao,Yuen Gao,Shuqin Zhang,Zhe Yang,Yunxia Liu,Xiaodong Zhang,Weiying Zhang,Lihong Ye +9 more
TL;DR: It is found that METTL3 promoted the expression of HBXIP through m6A modification, leading to accelerated cell proliferation in breast cancer, and this finding provides new insights into the mechanism of the mutual regulation betweenHBXIP andMETTL3 in the progression of breast cancer.
Journal ArticleDOI
WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
Yunhao Chen,Chuanhui Peng,Junru Chen,Diyu Chen,Beng Yang,Bin He,Wendi Hu,Yanpeng Zhang,Hua Liu,Longfei Dai,Haiyang Xie,Lin Zhou,Jian Wu,Shusen Zheng +13 more
TL;DR: This study is the first to report that WTAP-mediated m6A methylation has a crucial role in HCC oncogenesis, and highlights WTAP as a potential therapeutic target of HCC treatment.
Journal ArticleDOI
Distinct 5-methylcytosine profiles in poly(A) RNA from mouse embryonic stem cells and brain
Thomas Amort,Dietmar Rieder,Alexandra Wille,Daria Khokhlova-Cubberley,Christian Riml,Lukas Trixl,Xi-Yu Jia,Ronald Micura,Alexandra Lusser +8 more
TL;DR: This study presents the first comprehensive picture of cytosine methylation in the epitranscriptome of pluripotent and differentiated stages in the mouse and analyses potential correlations between m5C and micro RNA target sites, binding sites of RNA binding proteins, and N6-methyladenosine.